
"Determining infant survival status in demographic surveys is of great importance in analysis of infant mortality. Missing data representing age at death in complete months and complete years, if any, will affect the accuracy of any related measurement. A computer programme to reduce the percentage of such missing data is proposed."
Infertility is of particular concern in Africa because of the extent of the problem and the social stigma attached to it. The highest prevalence of infertility in Africa occurs south of the Sahara, but 5-8% of couples are estimated to experience infertility at some point in their reproductive lives (50-80 million people worldwide). The average infertility in Africa is 10.1% of couples, with a high of 32% in some countries, and certain tribes have high infertility rates. While primary infertility is higher in other regions of the world, secondary infertility is more common in Africa, and secondary infertility rates are very complicated to determine. The World Health Organization Task Force on the Diagnosis and Treatment of Infertility instituted a standardized approach to studies of infertility which was adopted in 33 countries. Between 1978 and 1982, a pilot study of this approach examined 8504 couples and found that less than 50% of male and female infertile partners were primarily infertile, and 66% did achieve a pregnancy within the union. The cause of infertility was not determined for 35% of the women and 50% of the infertile men in the sample. Infertility was accounted for by endocrine factors (usually menstrual or ovulatory disturbances) in 35% of infertile cases and tubal factors (such as unilateral or bilateral tubal occlusion, pelvic adhesion, and other abnormalities) in 32%. About 66% of African women experienced tubal factors compared to about 33% worldwide. About 9% of women reported a history of sexually transmitted disease (STD), and 8% reported abortion complications. 46% of men in sub-Saharan Africa reported a history of STDs. About 24% of women with primary infertility and 40% of women with secondary infertility had no previous history of pelvic inflammatory disease or STDs and had tubal disease. African infections are common due to inadequate health services, improper use of antibiotics, and penicillin-resistant strains of gonorrhea. Public health programs should be implemented to prevent infection-related infertility.
The aim of this work was to evaluate tubal and other pelvic pathologies through comparing the results obtained by hysterosalpingography (HSG) with that obtained by laparoscopy as a diagnostic procedure in infertile women. The study was performed at Al Hussein University Hospital from January 1989 to January 1990 and included 114 women attending the infertility clinic who had no contraindication to HSG or laparoscopy. All women were investigated by HSG using lipiodol and by laparoscopy under general anesthesia. According to the HSG results, the patients were classified into two groups. The first group included 18 women who had no abnormality by HSG, but 83% of them were found to have pathological findings on laparoscopy. On the other hand, the second group included 96 women who showed abnormal findings of HSG, but 23% of them were found to be normal by laparoscopy. The study presented a positive correlation between HSG and laparoscopy in 16.6% of cases in the first group and in 77% of cases in the second group. Hence, HSG and laparoscopy proved to be complementary to each other and should be regarded as essential procedures for complete infertility work-up.
Researchers followed 100 multiparous women who requested an IUD at the family planning clinic at El-Hussin University Hospital in Egypt 1, 3, 6, and 12 months after insertion of either the TCu-380 A or the TCu-200 B. They enrolled these women between September 1986-September 1987. The TCu-380 A had a higher continuation rate (89.7%) than the TCu-200 B (81.9%), but the difference was not significant (p=0.1). The continuation rate for TCu-380 A was higher than that of other studies (range 51.7-69.7%). The high continuation rate for TCu-380 A may have been due to careful selection of IUD candidates. For example, only multiparous women who had not had a pelvic infection after the last pregnancy and whose gynecological exam found no abnormalities were included. No one requested removal of the TCu-380 A because of bleeding and/or pain, but 8.7% of the TCu-200 B users did. Yet expulsion or displacement accounted for the leading reasons for removal of the TCu-380 A. Nevertheless the differences in reasons for removal between the 2 copper releasing IUDs were not statistically significant. No one with a TCu-380 A experienced a pregnancy, but the pregnancy rate for those with a TCu-200 B stood at 4 per 100 women-year. 46% of TCu-380 A users were 30 years old. Since higher pregnancy rates have occurred in women 30 years old at insertion than those 30 years old at insertion made the effectiveness rate of TCu-380 A all the more significant. In conclusion, if health workers properly screen women who wish to have an IUD, the TCu-380 A can be as effective in developing countries as it is in developed countries.